A Dr. Reddy's Laboratories spokesman says the Indian drugmaker is in talks to enter Japan's generics market. "Yes, we are looking at Japan and we are looking for partnerships," Dr Reddy's, Managing Director and COO Satish Reddy told reporters at a conference. According to a report on ET Now television, Dr. Reddy's is in talks with three Japanese drugmakers to buy a stake. In identified the three companies as Towa Pharmaceutical, Sawai Pharmaceutical and Fuji Pharma. However, the three companies all denied the report, Bloomberg notes. Article | Report